Clinical Trial

Topical Estrogen: Brief Intervention to Improve Postoperative Experience for Transgender Men Undergoing Hysterectomy

Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
The purpose of this study is to determine if applying a single dose of topical estrogen cream in the operating room at the end of your hysterectomy (removal of uterus and cervix) improves the postoperative experience with bleeding and potential symptoms of dysphoria (a feeling of discomfort or distress). Topical estrogen cream is sometimes used if patients have increased risk of bleeding with surgery but is not currently utilized in a consistent way. This study aims to answer the question of whether this is a helpful treatment and should be included in standard postoperative care.
Trial Details
NCT Number NCT06969326
Lead Sponsor Women and Infants Hospital of Rhode Island
Conditions Postoperative Bleeding, Gender Dysphoria, Hysterectomy
Enrollment 48 participants
Start Date 2025-05-01
Primary Completion 2026-09-01 (estimated)
Study Completion 2026-12-01 (estimated)
Updated on ClinicalTrials.gov 2025-05-13